Developer docs
API playgroundTry for free, no card

Search company profiles

MAK-SYSTEM International

Full company profile

uuid003e9t2

Namestring
MAK-SYSTEM International
Legal namestring
MAK-SYSTEM Ltd
Websiteurl
mak-system.com
Company typeenum
Private
Founded yearint
1984
Descriptiontext

MAK-SYSTEM International is a Paris-founded (1984), London-headquartered private healthcare software company that builds mission-critical information systems for blood establishments, plasma centres, hospital transfusion services, and cell/tissue/gene therapy organizations. Its portfolio spans four core products: eProgesa (a Blood Establishment Computer System, or BECS, handling 20,000 to 6 million units per year), P.H.S/eTraceLine (hospital transfusion management and reference lab software), Cosmas (cell, tissue and gene therapy orchestration supporting chain-of-identity and chain-of-custody for CAR-T and ATMP workflows), and eDRM (donor relationship management). All products are FDA 510(k) cleared or CE-marked under EU MDR 2017/746, and the suite is delivered either on-premise or via MAK.care, a cloud managed services platform launched in 2022 and built on AWS.

The technology stack is Java-based, cloud-native, and platform-agnostic with a service-oriented architecture designed for high-availability, multi-region resilience, and on-demand autoscaling. MAK.care extends the platform with a 24/7 global Security Operations Center, ransomware protection, encrypted cloud-native backups, and AI-powered observability. The company claims to manage approximately 1 in 3 blood transfusions globally, processing more than 30 million blood donations per year across 35 countries, with offices in the UK, US, France, Spain, Germany, Serbia, and North Macedonia. Notable customers include the New York Blood Center (10-year MAK.care deal), New Zealand Blood Service, Welsh Blood Service, and Northern Ireland Blood Transfusion Service.

MAK-SYSTEM generates revenue through software licensing and subscriptions for its four core products, multi-year managed services contracts on MAK.care (typically 10 years, priced via transaction fee or subscription with full cost visibility), and professional services for implementation, configuration, training, and post go-live support. Go-to-market is sales-led with a Global Commercial Director and Strategic Account Directors driving direct enterprise field sales to blood centres, hospitals, and biopharma customers globally, supplemented by a strong conference and event presence (AABB, ISCT, SABM), the long-standing International MAK User Group (IMUG) community, and a strategic AWS partnership. In July 2026, MAK-SYSTEM was acquired by Invita Health to extend end-to-end blood management solutions to organizations worldwide.

Short descriptiontext

MAK-SYSTEM International provides FDA-cleared and CE-marked healthcare software for blood establishments, plasma centres, hospital transfusion services, and cell/tissue/gene therapy organizations, managing roughly one in three global blood transfusions across 35 countries through its eProgesa, P.H.S/eTraceLine, Cosmas, and MAK.care cloud managed services platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
blood management software, transfusion management systems, cell therapy orchestration, healthcare cloud managed services, donor relationship management
Industry1 code
SECONDARYHLAGAEAI
Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code2 codes
  • Software Publishers51321
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Healthcare Blood Management Software
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Software Licensing and Subscription
TypeSubscription Recurring
Description

Traditional on-premise and cloud-hosted software licensing for ePROGESA, P.H.S/eTraceLine, Cosmas, and eDRM products. Can be deployed as on-premise or on-cloud (MAK.care) options.

mak-system.com
2Managed Services (MAK.care)
TypeManaged Services
Description

Full digital ecosystem management on behalf of clients delivered as managed service. Financial model offers full price visibility over contract term (typically 10 years) via transaction fee or subscription model. MAK manages entire digital ecosystem including backups, patching, 24/7 infrastructure, security operations, incident management, disaster recovery, and observability.

mak-system.com
3Professional Services
TypeProfessional Services
Description

Implementation services including configuration, project management, training, and post go-live support. Turn-key services to speed up implementation process and help with digital transformation.

mak-system.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain
Pricing details1 tier
1MAK.care Managed Services - Full ecosystem management
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Managed services model with price visibility over contract term (generally 10 years) via transaction fee or subscription. Includes full digital ecosystem management, 24/7 support, security, backups, and compliance.

mak-system.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1eProgesa (ePro)
Description

End-to-end blood and plasma management software for blood and plasma centers, enabling automation from donor recruitment through collection, processing, testing, release, inventory management, shipping and hospital ordering.

mak-system.com
+4 more records
Core offering1 text field

MAK-SYSTEM designs, develops and delivers regulated healthcare software for managing blood, plasma, tissue and cell products from donation to clinical application. Its portfolio includes eProgesa (BECS), P.H.S/eTraceLine (hospital transfusion), Cosmas (cell/gene therapy orchestration) and eDRM (donor relationship management), available on-premise or as the MAK.care cloud managed service on AWS.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 1 in 3 blood transfusions globally managed through MAK-SYSTEM systems
+3 more records
Product overview1 text field

MAK-SYSTEM offers a portfolio of advanced healthcare software solutions for managing blood, plasma, tissue, and cellular products from donation to clinical application. The product suite consists of: eProgesa (BECS for blood and plasma center management), P.H.S/eTraceLine (hospital transfusion management), Cosmas (cell, tissue and gene therapy orchestration), and eDRM (donor relationship management). These products are delivered either on-premises or via the MAK.care cloud managed services platform, enabling end-to-end automation from vein-to-vein.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-11-01
Description

Seven-year partnership supporting Digital Skills Development Programme for Women in Northern Ireland. Programme helps women gain essential IT and digital qualifications covering AI tool training, cybersecurity essentials, online safety, and digital career pathways.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-05-15
Description

Strategic partnership announced by NI Health Minister Robin Swann on May 15, 2024 to deliver state-of-the-art blood management system. First of its kind in UK and Europe enabling full blood tracking from donation to recipient. Replaces a 25-year-old system with end-to-end digital vein-to-vein donor management, blood production and tracking.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-11
Description

First national service managing blood and controlled human substances to transition to MAK.care cloud platform. Went live February 11, 2024 with full end-to-end automation of nationwide vein-to-vein operations from blood donation to transfusion, securely managed in the cloud.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-06-08
Description

10-year strategic partnership using MAK.Care platform to run entire digital ecosystem on behalf of NYBC. First national blood centre in USA to benefit from MAK.Care platform, transforming how blood is managed and delivered to patients.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-04-28
Description

Strategic partnership with AWS allowing more efficient and scalable connectivity for all stakeholders including blood centres, donors, healthcare providers, and pharmaceutical/biotech industries. MAK.care platform built on AWS Well-Architected Framework.

6Bytes
Strategic tierMinorTypeGTM or Marketing Partner
Description

Community partnership supporting Bytes' programmes focused on supporting young people, strengthening employability opportunities, and improving digital inclusion across Northern Ireland communities.

mak-system.com
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

ESG sustainability consultancy partnership providing strategic advice and independent monitoring and benchmarking for MAK-SYSTEM's ESG programme.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1BloodHub
TypeEmerging player
Description

BloodHub is a US-based SaaS vendor providing order management and inventory software specifically for hospital blood banks and blood centers. A more focused, emerging competitor to MAK-SYSTEM's ePROGESA and P.H.S/eTraceLine products in the US market.

TypeBroad incumbent
Description

Dedalus is a major European healthcare IT vendor providing diagnostic, clinical, and laboratory information systems including blood bank management. Overlap with MAK-SYSTEM in transfusion management and European hospital IT, and notably a previous employer of MAK's Chief Delivery Officer Pascal Gilbert-Jeantet.

TypeDirect peer
Description

WellSky provides healthcare interoperability and specialized software including blood bank and transfusion management solutions. Directly comparable to MAK-SYSTEM's hospital transfusion and blood center software, with overlap in donor management functionality.

4Haemonetics Corporation
TypeBroad incumbent
Description

Haemonetics is a global leader in blood and plasma component management, providing both hardware (blood collection devices) and software solutions for blood centers and plasma collectors. Direct overlap with MAK-SYSTEM's ePROGESA BECS and plasma center offerings, though Haemonetics is broader in scope including plasma collection devices and hemostasis management.

5Sunquest Information Systems
TypeDirect peer
Description

Sunquest provides laboratory and blood bank information systems used by hospitals and reference labs globally, including transfusion management solutions. Directly competes with MAK-SYSTEM's P.H.S/eTraceLine for hospital blood bank and transfusion software deployments.

TypeBroad incumbent
Description

Sysmex is a global leader in hematology and hemostasis diagnostics, with software solutions that interface with blood bank workflows. Comparable to MAK-SYSTEM in serving hematology and transfusion laboratories, though primarily a diagnostics hardware/instrument vendor rather than a BECS software vendor.

TypeRegional player
Description

Stratech distributes and supports blood bank and life science instrumentation across the UK and Ireland, often with associated software interfaces. Provides regional competition to MAK-SYSTEM's hospital transfusion deployments in Northern Ireland and the broader UK market.

TypeBroad incumbent
Description

Terumo BCT provides blood component collection, processing, and storage technologies for blood centers and plasma collectors globally. Comparable customer base to MAK-SYSTEM's ePROGESA deployments, though Terumo is primarily a medical device manufacturer rather than a software vendor.

TypeBroad incumbent
Description

Fresenius Kabi operates one of the world's largest plasma collection networks through its subsidiary and provides blood collection and transfusion medicine products. Adjacent to MAK-SYSTEM's plasma center customer base with overlap in transfusion medicine customers.

TypeBroad incumbent
Description

Epic's Beaker and integrated blood bank module is widely deployed in large US health systems and competes with MAK-SYSTEM's hospital-side transfusion management offering. While not a specialized BECS vendor, Epic's hospital EHR dominance creates bundling risk for MAK's P.H.S/eTraceLine product.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MAK-SYSTEM International

Healthcare Blood Management Softwaremak-system.com

MAK-SYSTEM International provides FDA-cleared and CE-marked healthcare software for blood establishments, plasma centres, hospital transfusion services, and cell/tissue/gene therapy organizations, managing roughly one in three global blood transfusions across 35 countries through its eProgesa, P.H.S/eTraceLine, Cosmas, and MAK.care cloud managed services platform.

What MAK-SYSTEM International does

MAK-SYSTEM International is a Paris-founded (1984), London-headquartered private healthcare software company that builds mission-critical information systems for blood establishments, plasma centres, hospital transfusion services, and cell/tissue/gene therapy organizations. Its portfolio spans four core products: eProgesa (a Blood Establishment Computer System, or BECS, handling 20,000 to 6 million units per year), P.H.S/eTraceLine (hospital transfusion management and reference lab software), Cosmas (cell, tissue and gene therapy orchestration supporting chain-of-identity and chain-of-custody for CAR-T and ATMP workflows), and eDRM (donor relationship management). All products are FDA 510(k) cleared or CE-marked under EU MDR 2017/746, and the suite is delivered either on-premise or via MAK.care, a cloud managed services platform launched in 2022 and built on AWS.

The technology stack is Java-based, cloud-native, and platform-agnostic with a service-oriented architecture designed for high-availability, multi-region resilience, and on-demand autoscaling. MAK.care extends the platform with a 24/7 global Security Operations Center, ransomware protection, encrypted cloud-native backups, and AI-powered observability. The company claims to manage approximately 1 in 3 blood transfusions globally, processing more than 30 million blood donations per year across 35 countries, with offices in the UK, US, France, Spain, Germany, Serbia, and North Macedonia. Notable customers include the New York Blood Center (10-year MAK.care deal), New Zealand Blood Service, Welsh Blood Service, and Northern Ireland Blood Transfusion Service.

MAK-SYSTEM generates revenue through software licensing and subscriptions for its four core products, multi-year managed services contracts on MAK.care (typically 10 years, priced via transaction fee or subscription with full cost visibility), and professional services for implementation, configuration, training, and post go-live support. Go-to-market is sales-led with a Global Commercial Director and Strategic Account Directors driving direct enterprise field sales to blood centres, hospitals, and biopharma customers globally, supplemented by a strong conference and event presence (AABB, ISCT, SABM), the long-standing International MAK User Group (IMUG) community, and a strategic AWS partnership. In July 2026, MAK-SYSTEM was acquired by Invita Health to extend end-to-end blood management solutions to organizations worldwide.

MAK-SYSTEM International firmographics

Firmographics
Name
MAK-SYSTEM International
Legal name
MAK-SYSTEM Ltd
Website
https://mak-system.com
Company type
Private
Founded year
1984
Operating status
Operating
Headcount range
101–250 employees
Short description
MAK-SYSTEM International provides FDA-cleared and CE-marked healthcare software for blood establishments, plasma centres, hospital transfusion services, and cell/tissue/gene therapy organizations, managing roughly one in three global blood transfusions across 35 countries through its eProgesa, P.H.S/eTraceLine, Cosmas, and MAK.care cloud managed services platform.
Ownership category
akta.pro rank

Where MAK-SYSTEM International is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices7 records

Markets served

MAK-SYSTEM International business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Software Licensing and Subscription: Traditional on-premise and cloud-hosted software licensing for ePROGESA, P.H.S/eTraceLine, Cosmas, and eDRM products. Can be deployed as on-premise or on-cloud (MAK.care) options.
  2. Managed Services (MAK.care): Full digital ecosystem management on behalf of clients delivered as managed service. Financial model offers full price visibility over contract term (typically 10 years) via transaction fee or subscription model. MAK manages entire digital ecosystem including backups, patching, 24/7 infrastructure, security operations, incident management, disaster recovery, and observability.
  3. Professional Services: Implementation services including configuration, project management, training, and post go-live support. Turn-key services to speed up implementation process and help with digital transformation.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractMAK.care Managed Services - Full ecosystem management

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

MAK-SYSTEM International product offering

Product offering

Core offering

MAK-SYSTEM designs, develops and delivers regulated healthcare software for managing blood, plasma, tissue and cell products from donation to clinical application. Its portfolio includes eProgesa (BECS), P.H.S/eTraceLine (hospital transfusion), Cosmas (cell/gene therapy orchestration) and eDRM (donor relationship management), available on-premise or as the MAK.care cloud managed service on AWS.

Product overview

MAK-SYSTEM offers a portfolio of advanced healthcare software solutions for managing blood, plasma, tissue, and cellular products from donation to clinical application. The product suite consists of: eProgesa (BECS for blood and plasma center management), P.H.S/eTraceLine (hospital transfusion management), Cosmas (cell, tissue and gene therapy orchestration), and eDRM (donor relationship management). These products are delivered either on-premises or via the MAK.care cloud managed services platform, enabling end-to-end automation from vein-to-vein.

Differentiator

Problem solved

Functional benefit

Brands

  • eProgesa (ePro): End-to-end blood and plasma management software for blood and plasma centers, enabling automation from donor recruitment through collection, processing, testing, release, inventory management, shipping and hospital ordering.
  • P.H.S / eTraceLine (eTL)
  • Cosmas / TCS
  • eDRM
  • MAK.care

Quantifiable outcome

  • 1 in 3 blood transfusions globally managed through MAK-SYSTEM systems
  • +3 more outcomes

Companies that use MAK-SYSTEM International

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

MAK-SYSTEM International technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability2 records

Feature5 records

MAK-SYSTEM International partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered minor and core.

  • WOMEN'STECminorGTM or Marketing Partner · 1 November 2025Seven-year partnership supporting Digital Skills Development Programme for Women in Northern Ireland. Programme helps women gain essential IT and digital qualifications covering AI tool training, cybersecurity essentials, online safety, and digital career pathways.
  • Northern Ireland Blood Transfusion ServicecoreStrategic or Co-development Partner · 15 May 2024Strategic partnership announced by NI Health Minister Robin Swann on May 15, 2024 to deliver state-of-the-art blood management system. First of its kind in UK and Europe enabling full blood tracking from donation to recipient. Replaces a 25-year-old system with end-to-end digital vein-to-vein donor management, blood production and tracking.
  • New Zealand Blood ServicecoreStrategic or Co-development Partner · 11 February 2024First national service managing blood and controlled human substances to transition to MAK.care cloud platform. Went live February 11, 2024 with full end-to-end automation of nationwide vein-to-vein operations from blood donation to transfusion, securely managed in the cloud.
  • New York Blood CentercoreStrategic or Co-development Partner · 8 June 202310-year strategic partnership using MAK.Care platform to run entire digital ecosystem on behalf of NYBC. First national blood centre in USA to benefit from MAK.Care platform, transforming how blood is managed and delivered to patients.
  • Amazon Web Services (AWS)coreTechnology or Integration · 28 April 2023Strategic partnership with AWS allowing more efficient and scalable connectivity for all stakeholders including blood centres, donors, healthcare providers, and pharmaceutical/biotech industries. MAK.care platform built on AWS Well-Architected Framework.
  • BytesminorGTM or Marketing PartnerCommunity partnership supporting Bytes' programmes focused on supporting young people, strengthening employability opportunities, and improving digital inclusion across Northern Ireland communities.
  • AnthesisminorImplementation/ SI/ Consulting PartnerESG sustainability consultancy partnership providing strategic advice and independent monitoring and benchmarking for MAK-SYSTEM's ESG programme.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

MAK-SYSTEM International competitors and assessment

Company assessment

Emerging players

  • BloodHub: BloodHub is a US-based SaaS vendor providing order management and inventory software specifically for hospital blood banks and blood centers. A more focused, emerging competitor to MAK-SYSTEM's ePROGESA and P.H.S/eTraceLine products in the US market.

Broad incumbents

  • Dedalus Group: Dedalus is a major European healthcare IT vendor providing diagnostic, clinical, and laboratory information systems including blood bank management. Overlap with MAK-SYSTEM in transfusion management and European hospital IT, and notably a previous employer of MAK's Chief Delivery Officer Pascal Gilbert-Jeantet.
  • Haemonetics Corporation: Haemonetics is a global leader in blood and plasma component management, providing both hardware (blood collection devices) and software solutions for blood centers and plasma collectors. Direct overlap with MAK-SYSTEM's ePROGESA BECS and plasma center offerings, though Haemonetics is broader in scope including plasma collection devices and hemostasis management.
  • Sysmex Corporation: Sysmex is a global leader in hematology and hemostasis diagnostics, with software solutions that interface with blood bank workflows. Comparable to MAK-SYSTEM in serving hematology and transfusion laboratories, though primarily a diagnostics hardware/instrument vendor rather than a BECS software vendor.
  • Terumo BCT: Terumo BCT provides blood component collection, processing, and storage technologies for blood centers and plasma collectors globally. Comparable customer base to MAK-SYSTEM's ePROGESA deployments, though Terumo is primarily a medical device manufacturer rather than a software vendor.
  • Fresenius Kabi: Fresenius Kabi operates one of the world's largest plasma collection networks through its subsidiary and provides blood collection and transfusion medicine products. Adjacent to MAK-SYSTEM's plasma center customer base with overlap in transfusion medicine customers.
  • Epic Systems (Blood Bank module): Epic's Beaker and integrated blood bank module is widely deployed in large US health systems and competes with MAK-SYSTEM's hospital-side transfusion management offering. While not a specialized BECS vendor, Epic's hospital EHR dominance creates bundling risk for MAK's P.H.S/eTraceLine product.

Direct peers

  • WellSky: WellSky provides healthcare interoperability and specialized software including blood bank and transfusion management solutions. Directly comparable to MAK-SYSTEM's hospital transfusion and blood center software, with overlap in donor management functionality.
  • Sunquest Information Systems: Sunquest provides laboratory and blood bank information systems used by hospitals and reference labs globally, including transfusion management solutions. Directly competes with MAK-SYSTEM's P.H.S/eTraceLine for hospital blood bank and transfusion software deployments.

Regional players

  • Stratech Scientific: Stratech distributes and supports blood bank and life science instrumentation across the UK and Ireland, often with associated software interfaces. Provides regional competition to MAK-SYSTEM's hospital transfusion deployments in Northern Ireland and the broader UK market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

MAK-SYSTEM International social profiles

Digital presence

MAK-SYSTEM International compliance and trust

Trust signal

Compliance9 records

MAK-SYSTEM International financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MAK-SYSTEM International leadership team

Management profile

Number of profiles

MAK-SYSTEM International funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MAK-SYSTEM International M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MAK-SYSTEM International

What does MAK-SYSTEM International do?

MAK-SYSTEM designs, develops and delivers regulated healthcare software for managing blood, plasma, tissue and cell products from donation to clinical application. Its portfolio includes eProgesa (BECS), P.H.S/eTraceLine (hospital transfusion), Cosmas (cell/gene therapy orchestration) and eDRM (donor relationship management), available on-premise or as the MAK.care cloud managed service on AWS.

Is MAK-SYSTEM International a public or private company?

MAK-SYSTEM International is a private company. It is classified as corporate owned and is currently operating.

When was MAK-SYSTEM International founded?

MAK-SYSTEM International was founded in 1984. It employs 101 to 250 people.

Where is MAK-SYSTEM International based?

MAK-SYSTEM International is headquartered in Paris, France, in the Europe region.

How does MAK-SYSTEM International make money?

Three revenue lines are on record. Software Licensing and Subscription is the primary driver. The others are managed Services (MAK.care) and professional Services.

Who are MAK-SYSTEM International's main competitors?

BloodHub is listed as an emerging player. Broad incumbents are Dedalus Group, Haemonetics Corporation, Sysmex Corporation, Terumo BCT, Fresenius Kabi and Epic Systems (Blood Bank module). Direct peers are WellSky and Sunquest Information Systems. Stratech Scientific is listed as a regional player.

Does MAK-SYSTEM International have an API?

No public API is recorded for MAK-SYSTEM International.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals